Jamaica gets 300,000 doses of AstraZeneca vaccines from UK

Jamaica received 300,000 doses of AstraZeneca vaccines from the United Kingdom on Friday, July 2021. 

PM Holness at Airport
PM Holness at Airport

Jamaica: Jamaica received 300,000 doses of AstraZeneca vaccines from the United Kingdom on Friday, July 2021. 

Consignment of vaccines reached the Norman Manley International Airport. It were received by Prime Minister Andrew Holness, Minister of Health and Wellness, Dr. Christopher Tufton, Minister of Foreign Affairs and Foreign Trade, Senator Kamina Johnson Smith, and the British High Commissioner, Asif Ahmad CMG. 

PM Holness said, ” I take the opportunity to express our gratitude to Prime Minister Boris and the people of the United Kingdom.”

In addition, ” We will launch an island-wide vaccination blitz tomorrow, July 31, 2021. Register now at moh.gov.jm.”

He also appealed to the people of Jamaica to vaccinated themselves against the coronavirus. 

Notably, UK has started delivering 9 million COVID-19 vaccines around the world to help tackle the Coronavirus pandemic.

In this programme, Indonesia will get 600,000 doses, Jamaica and 817,000 are to be transported to Kenya, among other countries.

Health Secretary of the United Kingdom Sajid Javid said, “This is a global pandemic and COVID-19 vaccines are the best way to protect people and prevent the emergence of new variants. We want to make sure developing nations can build a wall of defence against the virus as we have in the UK through our vaccine rollout.”

Also, five million vaccines are being offered to COVAX, the global scheme to get COVID-19 vaccines to developing nations to be delivered to the most vulnerable countries. 

Moreover, UK has also signed agreements with Antigua and Barbuda, Belize, Cambodia, Guyana, Indonesia, Jamaica, Kenya, Laos, Malaysia, Philippines, Saint Vincent and the Grenadines, Thailand and Vietnam to receive up to 4 million doses.

It is important to note that the UK provided £90 million to support the Oxford-AstraZeneca vaccine: £25 million on the initial research and development, and £65 million to scale up manufacturing.